Gelesis Holdings Inc (OTCPK:GLSHQ)

$ 0.0021 0 (0%) Market Cap: 154,000.00 Enterprise Value: 54.12 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 0/100

Q4 2022 Gelesis Holdings Inc Earnings Call - Pre-Recorded Transcript
Mar 28, 2023

$0.189 (+5.00%)

Earnings
Q3 2022 Gelesis Holdings Inc Earnings Call Transcript
Nov 14, 2022

$0.3635 (+5.36%)

Earnings
Gelesis Holdings Inc At IPO Edge Fireside Chat Transcript
Aug 17, 2022
Q2 2022 Gelesis Holdings Inc Earnings Call Transcript
Aug 15, 2022

$1.39 (-14.72%)

Earnings
Gelesis Holdings Inc at UBS Global Healthcare Conference Transcript
May 25, 2022
Q1 2022 Gelesis Holdings Inc Earnings Call Transcript
May 12, 2022

$4.7 (+3.75%)

Earnings
Q4 2021 Gelesis Holdings Inc Earnings Call Transcript
Mar 24, 2022

$5.76 (-6.34%)

Earnings
Gelesis Inc To Discuss Definitive Business Combination Agreement With PureTech Health PLC And Capstar Special Purpose Acquisition Corp Call Transcript
Jul 19, 2021

Q3 2022 Gelesis Holdings Inc Earnings Call Transcript

Nov 14, 2022 / 01:30PM GMT

Release Date Price: $0.3635 (+5.36%)

Transcript 10-Q8-K

Operator

Hello, and welcome to the Gelesis Third Quarter 2022 Earnings Conference Call. My name is Elliot, and I'll be coordinating your call today. (Operator Instructions) I would now like to hand over to our host, Anna Kate Heller, Investor Relations. The floor is yours. Please go ahead.

Anna Kate Heller

Good morning, everyone, and thank you for participating in today's conference call to discuss Gelesis' financial results for the third quarter ended September 30, 2022. Joining us today are Yishai Zohar, Founder and CEO of Gelesis; and Elliot Maltz, CFO of Gelesis. They will be discussing the fiscal 2022 third quarter and providing business updates on the company's commercial product, Plenity.

Before we begin today, I want to remind everyone this conference call may contain forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995, including statements relating to Gelesis' estimates of its future business outlook, prospects or financial results, including projected sales and EBITDA. Forward-looking statements generally can be

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.